HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
M Fukuoka Selected Research
M Fukuoka Research Topics
Disease
21
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 03/2000
11
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2017 - 05/2000
11
Neoplasms (Cancer)
06/2010 - 05/2000
7
Lung Neoplasms (Lung Cancer)
07/2010 - 03/2000
6
Neutropenia
01/2017 - 07/2000
3
Pneumonia (Pneumonitis)
09/2012 - 07/2000
3
Thrombocytopenia (Thrombopenia)
06/2004 - 07/2000
3
Asthma (Bronchial Asthma)
11/2001 - 01/2001
2
Febrile Neutropenia
01/2017 - 01/2013
2
Adenocarcinoma
01/2013 - 09/2012
2
Breast Neoplasms (Breast Cancer)
10/2002 - 09/2000
2
Anemia
12/2001 - 04/2000
2
Inflammation (Inflammations)
11/2001 - 06/2001
1
Disease Progression
01/2021
1
Leukopenia
01/2017
1
Interstitial Lung Diseases (Interstitial Lung Disease)
04/2015
1
Pancreatic Neoplasms (Pancreatic Cancer)
04/2013
1
Proteinuria
01/2013
1
Hypertension (High Blood Pressure)
01/2013
1
Body Weight (Weight, Body)
01/2013
1
Necrosis
05/2007
1
Infections
09/2006
1
Exanthema (Rash)
09/2006
1
Microscopic Polyangiitis
07/2005
1
Systemic Vasculitis
07/2005
1
Pain (Aches)
08/2002
1
Neck Pain (Cervicalgia)
08/2002
1
Stomach Neoplasms (Stomach Cancer)
10/2001
1
Peripheral Nervous System Diseases (PNS Diseases)
07/2001
1
Emphysema
06/2001
1
Pulmonary Fibrosis (Fibrosing Alveolitis)
06/2001
1
Cytomegalovirus Infections (Inclusion Disease)
04/2001
1
Chronic Hepatitis (Chronic Active Hepatitis)
01/2001
Drug/Important Bio-Agent (IBA)
14
Irinotecan (Camptosar)
FDA Link
Generic
02/2007 - 03/2000
12
Cisplatin (Platino)
FDA Link
Generic
06/2010 - 03/2000
5
ErbB Receptors (EGF Receptor)
IBA
01/2021 - 06/2003
5
Docetaxel (Taxotere)
FDA Link
01/2017 - 05/2000
5
Gefitinib (Iressa)
FDA Link
09/2012 - 06/2003
5
Carboplatin (JM8)
FDA Link
Generic
06/2010 - 07/2001
4
Gemcitabine
FDA Link
04/2013 - 05/2000
4
Etoposide (VP 16)
FDA Link
Generic
08/2005 - 07/2000
3
amrubicin
IBA
01/2017 - 05/2000
2
Bevacizumab (Avastin)
FDA Link
01/2021 - 01/2013
2
Erlotinib Hydrochloride (CP 358,774)
FDA Link
01/2021 - 04/2015
2
Platinum
IBA
01/2013 - 02/2007
2
Monoclonal Antibodies
IBA
02/2008 - 05/2000
2
Vinorelbine (Navelbine)
FDA Link
Generic
02/2007 - 05/2000
2
Topoisomerase I Inhibitors
IBA
08/2005 - 07/2001
2
Tyrosine Kinase Inhibitors
IBA
06/2003 - 05/2000
2
Messenger RNA (mRNA)
IBA
11/2001 - 06/2000
2
Doxorubicin (Adriamycin)
FDA Link
Generic
11/2001 - 09/2000
1
Equilibrative Nucleoside Transporter 1
IBA
04/2013
1
Enzymes
IBA
07/2010
1
Thymidylate Synthase
IBA
07/2010
1
Biological Products
IBA
07/2010
1
Thymidine
IBA
07/2010
1
sepantronium
IBA
06/2010
1
Inhibitor of Apoptosis Proteins
IBA
06/2010
1
Survivin
IBA
06/2010
1
Platinum Compounds (Compounds, Platinum)
IBA
06/2010
1
nimotuzumab
IBA
02/2008
1
soblidotin (TZT 1027)
IBA
05/2007
1
Alanine Transaminase (SGPT)
IBA
09/2006
1
Antineutrophil Cytoplasmic Antibodies (ANCA)
IBA
07/2005
1
Peroxidase (Myeloperoxidase)
IBA
07/2005
1
nedaplatin
IBA
06/2004
1
2- cyclohexylidenhydrazo- 4- phenyl- thiazole
IBA
02/2003
1
bisphenol A
IBA
10/2002
1
Sulfates (Sulfates, Inorganic)
IBA
10/2002
1
Erythropoietin
FDA Link
12/2001
1
Adenosine Triphosphate (ATP)
IBA
11/2001
1
Theophylline (Theon)
FDA Link
Generic
11/2001
1
ATP-Binding Cassette Transporters (ABC Transporters)
IBA
11/2001
1
Pharmaceutical Preparations
IBA
11/2001
1
Cholecalciferol (Vitamin D3)
FDA Link
07/2001
1
Nerve Growth Factor (NGF)
IBA
07/2001
1
1 alpha,24-dihydroxyvitamin D3 (Tacalcitol)
IBA
07/2001
1
Anti-Allergic Agents (Antiallergic Agents)
IBA
06/2001
1
Reactive Oxygen Species (Oxygen Radicals)
IBA
06/2001
1
suplatast tosilate
IBA
06/2001
1
Interleukin-8 (Interleukin 8)
IBA
06/2001
1
DNA (Deoxyribonucleic Acid)
IBA
04/2001
1
Immunoglobulin M (IgM)
IBA
04/2001
1
Allergens
IBA
01/2001
1
Carcinoembryonic Antigen
IBA
01/2001
1
Camptothecin
IBA
01/2001
1
Ovalbumin
IBA
01/2001
1
Alkaloids
IBA
01/2001
1
quinoline
IBA
01/2001
1
acarboxyprothrombin (PIVKA)
IBA
01/2001
1
alpha-Fetoproteins (alpha-Fetoprotein)
IBA
01/2001
1
satraplatin (JM 216)
IBA
09/2000
1
Antinuclear Antibodies
IBA
08/2000
Therapy/Procedure
8
Drug Therapy (Chemotherapy)
01/2021 - 04/2000
5
Therapeutics
07/2010 - 07/2001
4
Radiotherapy
09/2012 - 04/2000
3
Combination Drug Therapy (Combination Chemotherapy)
02/2003 - 07/2001
1
Induction Chemotherapy
09/2012
1
TP protocol
02/2007
1
Wheelchairs (Wheel Chair)
08/2002